31 reports

  • BRISTOL-MYERS SQUIBB (U.S.)

ENDOTOXIN TESTING IS USED IN CELL THERAPY, MONOCLONAL ANTIBODY TESTING, VACCINE TESTING, GENE THERAPY, AND DRUG DEVELOPMENT.

  • Biological Therapy
  • North America
  • Company
  • Product Initiative
  • Merck & Co., Inc.

ADCT conducts research on nextgeneration cancer biologic therapies.

  • Biological Therapy
  • Biopharmaceutical
  • North America
  • Company
  • Product Initiative

ADCT conducts research on nextgeneration cancer biologic therapies.

  • Biological Therapy
  • Cancer
  • Cell Therapy
  • North America
  • Product Initiative

IT IS A NEW BIOLOGICAL ENTITY (NBE).

  • Biological Therapy
  • Ear, Nose, And Throat Medicine
  • Healthcare
  • Hospital
  • North America

Treatment of bladder cancer includes chemotherapy, surgery, biological therapy and radiation therapy.

  • Biological Therapy
  • Bladder Cancer
  • Cancer
  • Pathology
  • North America

ADCT conducts research on nextgeneration cancer biologic therapies.

  • Biological Therapy
  • Cancer
  • Lymphoma
  • Pathology
  • North America

During the trial, a number of biological samples were collected prior to and after ONCOS-## treatment to evaluate the biological activity of the therapy.

  • Biological Therapy
  • Cancer
  • Colorectal Cancer
  • Pathology
  • North America

ADCT conducts research on nextgeneration cancer biologic therapies.

  • Biological Therapy
  • Cancer
  • Leukemia
  • North America
  • Product Initiative

AND TECHNOLOGY PARTNER DSM BIOLOGICS.

  • Biological Therapy
  • Cancer
  • Pathology
  • Pharmaceutical
  • North America

APCURE SAS APEIRON Biologics AG (APEIRON) is a biotechnology company that concentrates on the development of biological and immunological solutions for the treatment of various cancers.

  • Biological Therapy
  • Cancer
  • Pathology
  • Renal Cancer
  • North America

During the trial, a number of biological samples were collected prior to and after ONCOS-## treatment to evaluate the biological activity of the therapy.

  • Biological Therapy
  • Cancer
  • Pathology
  • Prostate Cancer
  • North America

AS SECONDARY AIM THE STUDY WILL EVALUATE TREATMENT RESPONSE TO THIS COMBINATION AND BIOLOGICAL MARKERS.

  • Biological Therapy
  • Brain Cancer
  • Cancer
  • Pathology
  • North America

During the trial, a number of biological samples were collected prior to and after ONCOS-## treatment to evaluate the biological activity of the therapy.

  • Biological Therapy
  • Cancer
  • Colorectal Cancer
  • Pathology
  • North America

During the trial, a number of biological samples were collected prior to and after ONCOS-## treatment to evaluate the biological activity of the therapy.

  • Biological Therapy
  • Cancer
  • North America
  • Company
  • Product Initiative

THE TRIAL SET OUT TO STUDY THE BIOLOGICAL EFFECTS OF THE DRUG COMBINATION BY MEASURING BIOLOGICAL MARKERS OF CELLULAR PROLIFERATION AFTER ## DAYS OF THERAPY.

  • Biological Therapy
  • Cancer
  • Monoclonal Antibody
  • North America
  • Product Initiative

IT IS A NEW BIOLOGICAL ENTITY (NBE).

  • Biological Therapy
  • Brain Cancer
  • Cancer
  • Pathology
  • North America

During the trial, a number of biological samples were collected prior to and after ONCOS-## treatment to evaluate the biological activity of the therapy.

  • Biological Therapy
  • Cancer
  • Ovarian Cancer
  • Pathology
  • North America

APCURE SAS APEIRON Biologics AG (APEIRON) is a biotechnology company that concentrates on the development of biological and immunological solutions for the treatment of various cancers.

  • Biological Therapy
  • Cancer
  • Pathology
  • Renal Cancer
  • North America

THE PRIMARY OUTCOME MEASURE WAS CLINICAL AND BIOLOGICAL TOXICITY OF COMBINED TREATMENT TIL, IL## ET AD- INFG.

  • Biological Therapy
  • Ear, Nose, And Throat Medicine
  • Healthcare
  • Hospital
  • North America

During the trial, a number of biological samples were collected prior to and after ONCOS-## treatment to evaluate the biological activity of the therapy.

  • Biological Therapy
  • Cancer
  • Ovarian Cancer
  • Pathology
  • North America

The company conducts clinical trials and research and development of novel biologics for the treatment of human malignancies and immune disorders.

  • Biological Therapy
  • Healthcare
  • Hepatitis
  • Pathology
  • North America

ADCT conducts research on nextgeneration cancer biologic therapies.

  • Biological Therapy
  • Cancer
  • Gastric Cancer
  • Pathology
  • North America

During the trial, a number of biological samples were collected prior to and after ONCOS-## treatment to evaluate the biological activity of the therapy.

  • Biological Therapy
  • Hospital
  • Pharmaceutical
  • Therapy
  • North America

ADCT conducts research on nextgeneration cancer biologic therapies.

  • Biological Therapy
  • Cancer
  • Gastric Cancer
  • North America
  • Product Initiative

ADCT conducts research on nextgeneration cancer biologic therapies.

  • Biological Therapy
  • Cancer
  • Lymphoma
  • Pathology
  • North America

ADCT conducts research on nextgeneration cancer biologic therapies.

  • Biological Therapy
  • Cancer
  • Leukemia
  • Pathology
  • North America

ADCT conducts research on nextgeneration cancer biologic therapies.

  • Biological Therapy
  • R&D
  • North America
  • Company
  • Product Initiative

IT IS A NEW BIOLOGICAL ENTITY (NBE).

  • Biological Therapy
  • Hepatitis
  • Pathology
  • Therapy
  • North America

THERAGENE HAS THE MOST ADVANCED AND EFFECTIVE BIOLOGICAL GENE THERAPY.

  • Biological Therapy
  • Biopharmaceutical
  • North America
  • Company
  • Product Initiative

Evidence of biologic activity was observed.

  • Biological Therapy
  • Cancer
  • Hepatitis
  • North America
  • Product Initiative